NCT04409626

Brief Summary

This study seeks to investigate if hyponatraemia be a direct contributor to death in schizophrenic and bipolar patients, and gauge the potential role of somatic comorbidity and psychotropic polypharmacy, with emphasis on antipsychotics and antidepressants.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
31,740

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
9.4 years until next milestone

First Submitted

Initial submission to the registry

May 27, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 1, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2020

Completed
Last Updated

June 1, 2020

Status Verified

May 1, 2020

Enrollment Period

9.5 years

First QC Date

May 27, 2020

Last Update Submit

May 27, 2020

Conditions

Keywords

CausalityBayesian analysisAntipsychoticsPsychotropicsPolypharmacy

Outcome Measures

Primary Outcomes (1)

  • Mortality

    All-cause mortality

    1 January 2011 through 1 July 2016

Study Arms (2)

Cases

Other: Plasma sodium level (continuous variables)

Controls

Matched (5 controls per case) by date of birth +/- 180 days.

Other: Plasma sodium level (continuous variables)

Interventions

Observational study, so the exposures of interest (5-year mean and minimum plasma sodium) are not administered to the patients. Ultimately, our interest is in hyponatraemia.

CasesControls

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Cases: * Died in our catchment area between 1 January 2011 and 1 July 2016. Controls: * 5 controls per case found by risk-set sampling with replacement, matched on date of birth +/- 180 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

HyponatremiaInappropriate ADH Syndrome

Condition Hierarchy (Ancestors)

Water-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesPituitary DiseasesHypothalamic DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2020

First Posted

June 1, 2020

Study Start

January 1, 2011

Primary Completion

July 1, 2020

Study Completion

August 1, 2020

Last Updated

June 1, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

We are unfortunately unable to share individual participant data, as our data source comprises sensitive information from electronic medical records and national registries.